Referanser
1. Quincke H. Über akutes umschriebenes
Hautödem. Monatsschr Prakt Dermat 1882; 1: 129
2. Hawthorne N. The House of the Seven
Gables. New York: Bantam; 1851. 1p.
3. Dennehy JJ. Hereditary angioneurotic
edema: report of a large kindred with defect in C-prime-1 esterase inhibitor and review of
the literature. Ann Intern Med 1970; 73: 55-9.
4. Donaldson VH, Rosen FS. Hereditary
angioneurotic edema: A clinical survey. Pediatrics 1966; 37: 1017-27.
5. Blohme G, Ysander K, Korsan-Bengtsen K,
Laurell AB. Hereditary angioneurotic oedema in three families. Acta med scand 1972; 19:
209-19.
6. Ohela K. Hereditary angioneurotic oedema
in Finland. Clinical. Acta med scand 1977; 201: 415-27.
7. Streuli R, Grob P. Untersuchung einer
grossen Sippe mit hereditärem angioneurotischem Ödem. Scweiz med Wschr 1975; 43: 1382-7.
8. Bork K. Hereditary angioedema
(HAE) due to
C1 esterase inhibitor deficiency. Biomed Progr 1990; 1: 9-13.
9. Moore GP, Hurley WT, Pace SA. Hereditary
angioedema. Ann Emerg Med 1988; 17: 1082-6.
10. Davis AE. C1 Inhibitor and hereditary
angioneurotic edema. Ann Rev Immunol 1988; 6: 595-628.
11. Agostoni A, Cicardi M. Hereditary and
acquired C1-inhibitor deficiency: biological and clinical characteristics in 235
patients.
Medicine Baltimore 1992; 71: 206-15.
12. Cicardi M, Bergamaschini L, Cugno M,
Beretta A, Zingale LC, Colombo M, Agostoni A. Pathogenetic and clinical aspects of C1
inhibitor deficiency. Immunobiology 1998; 199(2): 366-76.
13. Warin RP. The role of trauma in the
spreading weals of hereditary angio- oedema. Br J Dermatol 1983; 108: 189-94.
14. Lundh B, Laurell AB , Wetterqvist H,
White T, Granerus G. A case of hereditary angioneurotic oedema, successfully treated with
epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1
activation, plasminogen
level and histamine metabolism. Clin Exp Immunol 1968; 3: 733-45.
15. Arnoldsson H, Belin L, Hallberg L,
Helander E, Lindholm B, Westling H. Hereditary periodic oedema. Acta med scand 1967; 181:
115
16. Cohen N, Sharon A, Golik A, Zaidenstein
R, Modai D. Hereditary angioneurotic edema with severe hypovolemic shock. J Clin
Gastroenterol 1993; 16: 237-9.
17. Kennedy PS, Goyal RK, Hersh T. Hereditary
angioneurotic edema. A case with recurring abdominal pain. Am J Dig Dis 1972; 17: 435-8.
18. Zuraw BL. C1-Inhibitor Deficiency and
Autoimmunity. Immunol Allergy Clin N Amer 1993; 13: 441-57.
19. Marenah CB, Quiney JR. C1 esterase
inhibitor deficiency as a cause of abdominal pain. BMJ 1983; 286: 786-7.
20. Weinstock LB, Kothari T, Sharma RN,
Rosenfeld SI. Recurrent abdominal pain as the sole manifestation of hereditary angioedema
in multiple family members. Gastroenterology 1987; 93: 1116-8.
21. Shah TJ, Knowles WO , Mcgeady
SJ.
Hereditary angioedema with recurrent abdominal pain and ascites. J Allerg Clin Immunol
1995; 96: 259-61.
22. Shinzato T, Nakamura H, Kuniyoshi T,
Higashionna A, Uehara T, Oshiro J, Uechi H, Shikiya K, Sakugawa H, Kinjo F,
et-al.
Hereditary angioedema: a case with ascites yet no symptoms in the family. Intern Med 1992;
31: 633-5.
23. von-Schonfeld J, Olbricht T, Breuer N.
[Hereditary angioedema type II with predominantly abdominal symptoms]. Dtsch Med
Wochenschr 1991; 116: 973-6.
24. Burghardt W, Wernze H. Ultrasonography
for early diagnosis of hereditary angioneurotic oedema. Lancet 1987; 2(8551): 165-.
25. Laurent J, Toulet R , Lagrue G, Cicardi
M, Bergamaschini L, Marasini B, Boccasini G, Tucci A, Agostoni A. Ultrasonography in the
diagnosis of hereditary angioneurotic oedema (Letter). Lancet 1988; ii: 761-.
26. Reimold WV. Hereditäres Angioödem
(HAE)
mit akuter gastrointestinaler Symptomatik. Eine seltene Differentialdiagnose bei akutem
Abdomen. Med Klin 1987; 82: 900-7.
27. Collen MJ, Lewis JH , Deschner
WK, Ansher AF, Zurlo JJ, Benjamin SB, Frank MM. Abdominal pain in hereditary
angioedema: the role of
acid hypersecretion. Am J Gastroenterol 1989; 84: 873-7.
28. Granerus G, Hallberg L, Laurell AB,
Wetterquist H. Studies on the histamine metabolism and the complement system in hereditary
angioneurotic edema. Acta med scand 1967; 182: 11-22.
29. Lewis JH. Idiopathic gastric acid
hypersecretion: treatment implications for refractory acid/peptic disorders. Aliment
Pharmacol Ther 1991; 5 Suppl 1: 15-24.
30. Zeana C. Hereditary angioedema due to
deficit of C1-esterase inhibitor. Rev Roum Med -Med Int 1989; 27(2): 143-7.
31. Diaz-Isaacs M. [Hereditary
angioedema.
Review and presentation of 2 cases in a family]. Rev Med Panama 1991; 16: 143-50.
32. Nielsen EW, Kjernlie DF, Aaseth J.
Dødsfall av hereditært angioødem (A fatal outcome of hereditary
angio-oedema). Tidsskr
Nor Laegeforen 1995; 115(1): 43-4.
33. Wason IM. Angioneurotic
Edema. Report of
a case with necropsy findings. JAMA 1926; 86: 1332-3.
34. Frank MM, Gelfand JA, Atkinson
JP.
Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976; 84:
580-93.
35. Bajor K, Horgasz J, Husz S, Szilagyi I.
Sudden death due to pulmonary complication in a patient with hereditary
angioneuroticedema. Dermatol Monatschr 1983; 169: 468-70.
36. Coudry H, Durrleman E, Chobaut
JC, Agache
P, Laurent R. Glottic localizations of hereditary angioneurotic edema.
[French]. JFORL J
Fr Otorhinolaryngol Audiophonol Chir Maxillofac 1976; 25: 141-5.
37. Legendre M, Chiche JF, Molina C, Grouffal
C, Betail G. Respiratory manifestations in hereditary angioneurotic edema.
[French]. Rev
Pneumol Clin 1985; 41: 251-8.
38. Juhlin L, Michaelsson G. Vascular
reactions in hereditary angioneurotic edema. Acta Derm Venereol (Stockh) 1969; 49: 20-5.
39. Van Dellen RC, Myers RP. Bladder
involvement in hereditary angioedema. Mayo Clin Proc 1980; 55: 277-8.
40. Starzia Z, Hegyi E, Kuklinek P, Cap J,
Stefanovic J, Lokaj J. Hereditary angioedema in Czechoslovakia. Clinical,
immunological,
genetic and therapeutic studies in 16 families. Allerg Immunol 1988; 34: 35-42.
41. Perricone R, Pasetto N, Decarolis C,
Vaquero E, Noccioli G, Panerai AE, Fontana L. Cystic Ovaries in Women Affected with
Hereditary Angioedema. Clin Exp Immunol 1992; 90: 401-4.
42. Cunningham DS, Jensen JT. Hereditary
angioneurotic edema in the puerperium. A case report. J Reprod Med 1991; 36: 312-3.
43. Khristova S. [A combination of chronic
kidney failure with hereditary angioedema]. Vutr Boles 1990; 29: 114-7.
44. Krause KH, Rentrop U, Mehregan U.
Cerebral manifestations in angioneurotic edema (author's transl). [German]. J Neurol Sci
1979; 42: 429-35.
45. Brettle RP, Dunmow RE, Milne LA, Yap PL.
Angioneurotic oedema in the elderly. Scott Med J 1982; 27: 309-11.
46. Elnicki DM. Hereditary angioedema. South
Med J 1992; 85 : 1084-90.
47. Hoffman U, Buss J, Voigtlaender P,
Bernbeck U, Heene D. Hereditary angioedema and Aortitis. Abstract. Klin Wochenschr 1987;
65: 885-7.
48. Donaldson VH. Hereditary angioneurotic
edema. Dis Mon 1979; 26: 1-37.
49. Ley SJ, Williams RC . A family with
hereditary angioedema and multiple immunologic disorders. Am J Med 1987; 82: 1046-51.
50. Brickman CM, Tsokos GC, Balow JE, Lawley
TJ, Santaella M, Hammer CH, Frank MM. Immunoregulatory disorders associated with
hereditary angioedema. J Allergy Clin Immunol 1986; 77: 749-57.
51. Hory B, Haultier JJ . Glomerulonephritis
and hereditary angioedema: Report of 2 cases. Clin Nephrol 1989; 5: 259-63.
52. Agnello V. Lupus diseases associated with
hereditary and acquired deficiencies of complement. Springer Semin Immunopathol 1986; 9:
161-78.
53. Duncan IJS, Tymms KE, Carney G.
Rheumatoid arthritis and hereditary angioedema. J Rheumatol 1988; 15: 700-2.
54. Youinou P, Dorval JC, Cledes J, Leroy JP,
Miossec P, Masse R. A study of familial lupus erythematosus-like disease and hereditary
angio-oedema treated with danazol. Br J Dermatol 1983; 108: 717-22.
55. Hory B, Blanc D. Renal manifestations of
hereditary angioedema [letter]. Am J Med 1991; 90: 661-2.
56. Nomura H, Tsugawa Y , Koni I, Tofuku Y,
Mabuchi H, Takeda R, Sato T. Hereditary angioedema complicated with chronic renal failure:
report of sibling cases. Intern Med 1992; 31: 94-7.
57. Pan CG, Strife CF, Ward MK, Spitzer RE,
McAdams AJ. Long-term follow-up of non-systemic lupus erythematosus glomerulonephritis in
patients with hereditary angioedema: report of four cases. Am J Kidney Dis 1992; 19:
526-31.
58. Harrington TM, Toretti D, Pytko VF,
Plotkin GR. Hereditary angioedema and coronary arteritis. Am J Med Sci 1984; 287: 50-2.
59. Vanbommel EFH, Ouwehand AJ, Mulder AH,
Weimar W. Mesangiocapillary glomerulonephritis associated with hereditary angioedema.
Nephron 1995; 69: 178-9.
60. Tenner AJ, Frank MM . Activator-bound C1
is less susceptible to inactivation by C1 inhibition than is fluid-phase C1. J Immunol
1986; 137: 625-30.
61. Hosoi S, Circolo A, Borsos T. Activation
of human C1: analysis with Western blotting reveals slow self-activation. J immunol 1987;
139: 1602-8.
62. Laurell AB, Martensson U, Sjoholm AG.
Spontaneous generation in human serum of a trimer complex containing C1 Inactivator,
activated C1r and zymogen C1s. J Immunol 1987; 139: 4145-51.
63. Ziccardi RJ. The first component of human
complement (C1): activation and control. [Review]. Springer Semin Immunopathol 1983; 6:
213-30.
64. Sjoholm AG. Inherited complement
deficiency states: implications for immunity and immunological disease. APMIS 1990; 98:
861-74.
65. Morgan BP, Walport MJ. Complement
deficiency and disease. Immunol Today 1991; 12: 301-6.
66. Whaley K, Ahmed AE. Control of immune
complexes by the classical pathway. Behring Inst Mitt 1989; (84): 111-20.
67. Donaldson VH, Hess EV, McAdams AJ.
Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic
edema. Ann Intern Med 1977; 86: 312-3.
68. D'Amelio R, Perricone R, De Carolis C,
Pontesilli O, Matricardi PM, Fontana L. Immune complexes in hereditary angioneurotic edema
(HANE). J Allergy Clin Immunol 1986; 78: 486-7.
69. Blockers M, Bork K. Kontrazeption und
Schwangerschaft beim hereditaeren Angioödem. Dtsch Med Wschr 1987; 112: 507-9.
70. Farber C-M, Gourdin A, Lambermont M,
Gilbert C, Van Vooren J-P. Substitution therapy for C1 esterase deficiency. Lancet 1992;
339: 119-.
71. Borradori L, Marie O, Rybojad M, Vexiau
P, Morel P, Spath PJ. Hereditary angioedema and oral contraception [letter]. Dermatologica
1990; 181: 78-9.
72. Yip J, Cunliffe WJ. Hormonally
exacerbated hereditary angioedema. Australas J Dermatol 1992; 33: 35-8.
73. Weidenbach H, Beckh KH, Lerch MM, Adler
G. Precipitation of Hereditary Angioedema by Infectious Mononucleosis. Lancet 1993; 342:
934-5.
74. Nielsen EW, Skjeflo H. [Hereditary
angioedema]. Nor Tannlaegeforen Tid 1991; 101: 10-1.
75. Scher I. Angioneurotic edema. O S,O M
& O P 1963; 16: 286-90.
76. Heidemann D, Bork K . Lebensbedrohliche
Larynxödeme durch geringfügige zahnärztliche Eingriffe beim hereditären
angioneurotischen ödem. Dstch zahnärztl Z 1979; 34: 430-2.
77. Phillips KM, Glick M, Cohen SG.
Hereditary angioedema: report of case. Spec Care Dentist 1989; 9: 23-6.
78. Hardie J, Ringland T, Yang WH, Wagner V.
Potentially fatal hereditary angioedema: a review and case report. J Can Dent Assoc 1990;
56: 1096-9.
79. Atkinson JC, Frank MM. Oral
manifestations and dental management of patients with hereditary angioedema. J Oral Pathol
Med 1991; 20: 139-42.
80. Hurley JE, Rayden MR. Hereditary
angio-oedema in relation to dentistry. Br J Oral Surg 1978; 16: 26-30.
81. Degroote DF, Smith GL, Huttula GS. Acute
airway obstruction following tooth extraction in hereditary angioedema. J Oral Maxillofac
Surg 1985; 43: 52-4.
82. Starr JC, Brasher GW. Hereditary
angioedema with 14-year remission. South Med J 1975; 68: 1184-5.
83. Bock SC, Skriver K, Nielson E, Thorgerson
H-C, Wiman B, Donaldson VH, Eddy RL, Marrinan J, Radziewska E , Huber R, Shows TB,
Magnusson S. Human C1 inhibitor:Primary structure, cDNA cloning, and chromosomal
localization. Biochemistry 1986; 25: 4292-301.
84. Verpy E, Biasotto M , Brai M, Misiano G,
Meo T, Tosi M. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis
discloses new genotype-phenotype correlations in angioedema. Am J Hum Genet 1996; 59(2):
308-19.
85. Verpy E, Couture Tosi E, Eldering E,
Lopez Trascasa M, Spath PJ, Meo T, Tosi M. Crucial residues in the carboxy-terminal end of
C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J Clin
Invest 1995; 95: 350-9.
86. Eldering E, Verpy E , Roem D, Meo T, Tosi
M. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion
and subsequent multimerization. J Biol Chem 1995; 270: 2579-87.
87. Kramer J, Rosen FS, Colten HR, Rajczy K,
Strunk RC. Transinhibition of C1 Inhibitor Synthesis in Type-1 Hereditary Angioneurotic
Edema. J Clin Invest 1993; 91: 1258-62.
88. Doekes G, Van-Es LA , Daha MR. C1
inactivator: its effciency as a regulator of classical complement pathway activation by
soluble IgG aggregates. Imunology 1983; 49: 215-22.
89. Lachmann PJ, Rosen FS. The catabolism of
C1 inhibitor and the pathogenesis of hereditary angio-edema. Acta path microbiol immunol
scand 1984; 92: 35-9.
90. Willms K, Rosen FS, Donaldson VH.
Observations on the ultrastructure of lesions induced in human and guinea pig skin by C 1
esterase and polypeptide from hereditary angioneurotic edema (HANE) plasma. Clin Immunol
Immunopathol 1975; 4: 174-88.
91. Fields T, Ghebrehiwet B, Kaplan AP. Kinin
formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and
in support of "spontaneous" formation of bradykinin. J Allerg Clin Immunol 1983;
72: 54-60.
92. Schapira M, Silver LD, Scott CF, Schmaier
AH, Prograis LJ, Curd JG, Colman RW. Prekallikrein activation and high-molecular-weight
kininogen consumption in hereditary angioedema. N Engl J Med 1983; 308: 1050-4.
93. Schapira M, de-Agostini A, Colman RW. C1
inhibitor: the predominant inhibitor of plasma kallikrein. Methods Enzymol 1988; 163:
179-85.
94. Nussberger J, Cugno M, Amstutz C, Cicardi
M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351(9117):
1693-7.
95. Strang CJ, Cholin S , Spragg J, Davis AE,
Schneeberger EE, Donaldson VH, Rosen FS. Angioedema induced by a peptide derived from
complement component C2. J Exp Med 1988; 168: 1685-98.
96. Shoemaker LR, Schurman SJ, Donaldson VH,
Davis AE. Hereditary Angioneurotic Oedema - Characterization of Plasma Kinin and Vascular
Permeability-Enhancing Activities. Clin Exp Immunol 1994; 95: 22-8.
97. Hugli TE, Kawahara MS, Unson CG,
Molinar-Rode R, Erickson BW. The active site of human C4a anaphylatoxin. Mol Immunol 1983;
20: 637-45.
98. Lung CC, Chan EKL, Zuraw BL. Analysis of
an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal
subjects and patients with C1 inhibitor deficiency. J Allerg Clin Immunol 1997; 99(1):
134-46.
99. Ruddy S. Hereditary angioedema.
Undersuspected, underdiagnosed. Hosp Pract Off 1988; 23: 91-6, 99-100.
100. Feller EJ, Spiro HM, Katz LA. Hereditary
angioneurotic oedema: an unusual cause of recurring abdominal pain. Gut 1970; 11: 983-8.
101. Small P, Frenkiel S. Hereditary
angioneurotic edema first observed as an epiglottiditis. Arch Otolaryngol 1983; 109:
195-6.
102. Morris GE, Slavin BM, Browse NL.
Hereditary angioneurotic oedema: a neglected diagnosis. J Clin Pathol 1987; 40: 516-7.
103. Gjonnaess HA. Cold promoted activation
of factor VII. I. Evidence for the existence of an activator. Thromb Diath Haemorrh 1972;
28 : 155-68.
104. Patston PA, Gettins P, Beechem J,
Schapira M. Mechanism of serpin action: Evidence that C1 inhibitor functions as a suicide
substrate. Biochemistry 1991; 30: 8876-82.
105. Donaldson VH. Cold enhancement of blood
coagulation: observations on the role of C1-inhibitor. Acta path microbiol immunol scand
1984; 92: 41-7.
106. Nilsson T, Back O. On the role of
C1-esterase inhibitor in cold urticaria. Acta Derm Venerol 1984; 64: 197-202.
107. VanRoyen EA, Lohmann S, Voss M, Pondmann
KW. C1 inaktivator and cold-promoted activation of factor VII. J Lab Clin Med 1978; 92:
152-63.
108. Czendlik C, Lämmle B, Duckert F. Cold
promoted activation and factor XII, prekallikrein and C1- inhibitor. Thromb Haemost 1985;
242-4.
109. Spath PJ, Wuthrich B. Angioedema. A
review on the acquired, allergic or non-allergic, and the hereditary forms. Recenti Prog
Med 1990; 81: 513-31.
110. Frank MM. Complement in the
pathophysiology of human disease. N Engl J Med 1987; 316: 1525-30.
111. Alsenz J, Bork K, Loos M.
Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med 1987; 316: 1360-6.
112. Bork K, Alsenz J, Böckers M, Noah E,
Loos M. IgG-Antikörperbildung gegen C1-Inhibitor als Ursache Lebensbedrohlicher
Angioödeme. Dtsch med Wschr 1987; 112: 503-6.
113. Morrison RCA, Rabson AR. The late onset
form of C1 esterase-inhibitor deficiency presenting as food allergy. J Allergy Clin
Immunol 1987; 79: 336-9.
114. Malbran A, Hammer CH, Frank MM, Fries
LF. Acquired angioedema: observations on the mechanism of action of autoantibodies
directed against C1 esterase inhibitor. J Allergy Clin Immunol 1988; 81: 1199-204.
115. Jackson J, Sim RB, Whelan A, Feighery C.
An IgG autoantibody which inactivates C1-inhibitor. Nature 1986; 323: 722-4.
116. Rodriguez M, Ancochea J, De Buen C,
Merino JL, Marquës G, Vivanco F. Acquired C1-inhibitor deficiency associated with a
lupus-like anticoagulant activity. Ann Allergy 1988; 61: 348-50.
117. Wozel G, Rietzschel I. Erworbener
C1-Esterase-Inhibitor-Mangel, persistierende Lidoedeme und subakuter Lupus erythematodes.
[Acquired deficiency of C1 esterase inhibitor, persistent eyelid edema and subacute lupus
erythematosus]. Dermatol Monatsschr 1988; 174: 741-7.
118. Alsenz J, Lambris JD, Bork K, Loos M.
Acquired C1 Inhibitor (C1-INH) Deficiency type II. J Clin Invest 1989; 83: 1794-9.
119. Donaldson VH, Bernstein DI, Wagner CJ,
Mitchell BH, Scinto J, Bernstein IL. Angioneurotic edema with acquired C(1)bar inhibitor
deficiency and autoantibody to C(1)bar inhibitor-response to plasmapheresis and cytotoxic
therapy. J Lab Clin Med 1992; 119: 397-406.
120. Bain BJ, Catovsky D, Ewan PW. Acquired
Angioedema as the Presenting Feature of Lymphoproliferative Disorders of Mature
B-Lymphocytes. Cancer 1993; 72: 3318-22.
121. Ciaccia D, Brazer SR, Baker ME. Acquired
C1 Esterase Inhibitor Deficiency Causing Intestinal Angioedema - CT Appearance - Case
Report. Am J Roentgenol 1993; 161: 1215-6.
122. Cicardi M, Bisiani G, Cugno M, Spath PJ,
Agostoni A. Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med 1993;
95: 169-75.
123. Delmer A, Garban F , Letourneau A,
Conard J, Weiss L, Diebold J, Zittoun R. Waldenstroms Macroglobulinemia with Prominent
Splenomegaly and Multiple Immune Disorders. Haematologica 1993; 78: 408-10.
124. Eck SL, Morse JH, Janssen DA, Emerson
SG, Markovitz DM. Angioedema presenting as chronic gastrointestinal symptoms. Am J
Gastroenterol 1993; 88: 436-9.
125. Wasserfallen JB, Spaeth P, Guillou L,
Pecoud AR. Acquired deficiency in C1-inhibitor associated with signet ring cell gastric
adenocarcinoma: A probable connection of antitumor- associated antibodies, hemolytic
anemia, and complement turnover. J Allerg Clin Immunol 1995; 95: 124-31.
126. Jackson J, Sim RB, Whaley K, Feighery C.
Autoantibody fascilitated cleavage of C1-inhibitor in autoimmune angioedema. J Clin Invest
1989; 83: 698-707.
127. Blohme G. Treatment of hereditary
angioneurotic oedema with tranexamic acid. A random double-blind cross-over study. Acta
med scand 1972; 192: 293-8.
128. Lundh B. Tranexamic acid in hereditary
angioedema-a progress report. N Engl J Med 1973; 288: 53-.
129. Sheffer AL, Austen KF, Rosen FS.
Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med 1972; 287: 452-4.
130. Gelfand JA, Sherins RJ, Alling DW, Frank
MM. Treatment of hereditary angioedema with danazol. N Engl J Med 1976; 295: 1444-8.
131. Tappeiner G, Hintner H, Glatzl J, Wolff
K. Hereditary angio-oedema: treatment with danazol. Br J Dermatol 1979; 100: 207-12.
132. Gadek JE, Hosea SW , Gelfand JA,
Santaella M, Wickerhauser M, Triantaphyllopoulos DC, Frank MM. Replacement therapy in
hereditary angioedema. N Engl J Med 1980; 302: 542-6.
133. Rajagopal C, Harper JR. Successful use
of danazol for hereditary angioedema. Arch Dis Child 1981; 56: 229-30.
134. Myreng Y, Holst T. Behandling av
hereditært angioødem med danazol. Tidsskr Nor Laegeforen 1983; 103: 2050-1.
135. Zurlo JJ, Frank MM . The long-term
safety of danazol in women with hereditary angioedema. Fertil steril 1990; 54: 64-72.
136. Cicardi M, Bergamaschini L, Cugno M,
Hack E, Agostoni G, Agostoni A. Long-term treatment of hereditary angioedema with
attenuated androgens: a survey of a 13-year experience. J Allergy Clin Immunol 1991; 87:
768-73.
137. Robinson LC, Hart LL. Danazol in
Hereditary Angioedema. Ann Pharmacoter 1992; 26: 1251-2.
138. Barakat A, Castaldo AJ. Hereditary
angioedema: danazol therapy in a 5-year-old child [letter]. Am J Dis Child 1993; 147:
931-2.
139. Hosea SW, Santaella ML, Brown EJ, Berger
M, Katusha K, Frank MM. Long-term therapy of hereditary angioedema with danazol. Ann Int
Med 1980; 93: 809-12.
140. Agostoni A, Bergamaschini L, Martignoni
G, Cicardi M, Marasini B. Treatment of acute attacks of hereditary angioedema with C1-
inhibitor concentrate. Ann Allergy 1980; 44: 299-301.
141. Greaves M, Lawlor F. Angioedema:
manifestations and management. J Am Acad Dermatol 1991; 25: 155-61; discus.
142. Brickman CM, Frank MM, Kaliner M.
Urine-histamine levels in patients with hereditary angioedema (HAE). J Allergy Clin
Immunol 1988; 82: 403-6.
